<DOC>
	<DOCNO>NCT01478997</DOCNO>
	<brief_summary>This study determine whether Flexsure Safe , Tolerable Effective relieving symptom Moderate Osteoarthritis Knee .</brief_summary>
	<brief_title>A Study Moderate Osteoarthritis Knee</brief_title>
	<detailed_description>Primary efficacy variable : Number patient show 20 % reduction baseline WOMAC - pain subscale Secondary efficacy variable : - Number patient show 50 % reduction baseline WOMAC - pain subscale - Number patient show 20 % reduction baseline VAS-pain - Number patient show 50 % reduction baseline VAS- pain - Mean change ( percentage reduction ) WOMAC score pain , stiffness physical function baseline , compare placebo - Mean change ( percentage reduction ) VAS - pain , assess clinic visit daily record patient diary ( First two week ) - Consumption rescue medication - Investigator 's Global assessment efficacy - Subject 's global assessment efficacy</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Ambulatory male female patient age 3065 year , diagnose OA knee accord ACR clinical radiographic criterion ARA functional class II III Kellgren Lawrence radiological severity Grade II , Grade III OA knee Maximal OA pain movement , measure 0100 Visual analog scale ( VAS ) 40 less 80 previous 24 hr screen baseline visit Conditions mimic OA knee pain , E.g . rheumatoid arthritis , systemic lupus erythematosus , gout , psoriatic arthritis , pseudo gout pain due malignant disease BMI &gt; 35 kg/m2 Indication surgery OA knee Arthroscopy either knee past year Use analgesic symptomrelieving medication within 7 day screen Use systemic steroid herbal medication OA within 4 week screen Use Vit . D3 injection , Glucosamine sulphate , Chondroitin sulphate , Diacerin , Alendronate past 3 month Administration intraarticular steroid past 3 month hyaluronic acid last 9 month History osteoporotic/ osteoarthritic fracture within past 6 month Pregnant lactate woman woman inadequate contraceptive measure Evidence clinical suspicion major medical condition ( E.g . uncontrolled diabetes mellitus , uncontrolled hypertension , cardiovascular disease , thyroid , hepatic , renal dysfunction ) Presence clinically significant laboratory anomaly Known case AIDS ( HIV positive ) History Coronary Angioplasty/CABG within past 2 year Moderate severe peripheral neuropathy neurological disorder Alcohol abuse , medication drug dependence Concurrent previous participation clinical study within previous 6 week</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>